Vijay Chiruvolu
Director Técnico/Científico/I+D en TURNSTONE BIOLOGICS CORP. .
Fortuna: - $ al 31/05/2024
Cargos activos de Vijay Chiruvolu
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TURNSTONE BIOLOGICS CORP. | Director Técnico/Científico/I+D | 01/03/2023 | - |
Historial de carrera de Vijay Chiruvolu
Antiguos cargos conocidos de Vijay Chiruvolu.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INSTIL BIO, INC. | Director Técnico/Científico/I+D | 01/07/2020 | 02/09/2022 |
KITE PHARMA INC | Corporate Officer/Principal | - | - |
Formación de Vijay Chiruvolu.
The University of Nebraska-Lincoln | Doctorate Degree |
The Pennsylvania State University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
INSTIL BIO, INC. | Health Technology |
TURNSTONE BIOLOGICS CORP. | Health Technology |
Empresas privadas | 1 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Vijay Chiruvolu
- Experiencia